Close Menu
    What's Hot

    Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    July 23, 2026

    Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

    July 23, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      July 23, 2026

      Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 23, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      July 23, 2026

      Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 23, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    The Legacy of the Pandemic for Pension Scheme Mortality

    Mortality February 8, 2023By Stuart McDonald
    Covid-19 Resilience
    Share
    Twitter LinkedIn Email

    The Covid-19 pandemic has caused a dramatic shock to health and life expectancy, disrupting the pattern of mortality improvement seen historically in the UK population.

    Since March 2020, we have witnessed over 160,000 excess deaths compared to what would have been expected if mortality rates had remained at pre-pandemic levels. Early on, the vast majority of excess deaths were a direct consequence of Covid infections. As time goes on though we are increasingly also seeing excess deaths arise from indirect impacts of the pandemic such as disruption to the health system and changes to individual health-seeking behaviour. Medical diagnoses have been missed or delayed – for example, 2020 saw large falls in new prescriptions to manage blood pressure and cholesterol levels, which have not been caught up. In December 2022 the average ambulance response time in England for category 2 calls (which can include strokes and heart attacks) was over one and a half hours. That is against a target of 18 minutes.

    Whilst most direct deaths from Covid-19 were among older people, the relative increase in mortality rates was broadly comparable across all age groups in 2020. As time has gone on and indirect impacts have increasingly influenced mortality rates, it is younger adults experiencing the biggest relative increase. Many of these excess deaths are from cardiovascular causes.

    Age is certainly not the only relevant lens through which to view the impacts of Covid-19. Clear differences have been apparent at various stages of the pandemic when looking at other demographic, geographic and socioeconomic indicators. For example, the most deprived fifth of the population experienced disproportionately high excess mortality during the first wave. This was partly because they were more likely to be in occupations that exposed them to the virus, and partly due to prevalence of health conditions that made serious illness and death more likely.

    The pandemic presents a significant challenge to pension scheme trustees and sponsors on the allowance that should be made for Covid-19 when adopting mortality assumptions for their schemes. When giving advice on mortality assumptions, actuaries tend to use models which project future mortality rates based on past data. Given the volatility of recent data, these models may now produce unreliable forecasts or require more significant subjective adjustment than previously. The latest model of mortality improvement from the Continuous Mortality Investigation (CMI) makes no allowance for Covid-19 by default.

    This means that it has never been more important to understand the underlying drivers of changes to mortality, and how these affect different groups. Some drivers will have a comparable impact on all of society, but others may affect members of a specific pension scheme differently to other pension schemes or the general population. For example, a scheme’s membership might be concentrated in a region where waiting lists are particularly long and the local population’s unmet healthcare needs are significant.  

    Even before the pandemic struck, there was extreme longevity inequality in the UK, with an astonishing 27-year gap between the life expectancy at birth of men in the local areas with the highest and lowest life expectancy. The life expectancy gap was widening pre-pandemic and we expect it to continue to do so for at least the next few years. What happens beyond that is harder to say as it depends in large part on political choices. One of the UK Government’s “Grand Challenge” missions is to “ensure that people can enjoy at least five extra healthy, independent years of life by 2035, which narrowing the gap between the experience of the richest and poorest”. The Covid-19 pandemic will make this ambitious goal even more challenging to deliver.

    Stuart McDonald is a Partner and Head of Longevity and Demographic Insights at Lane Clark & Peacock LLP


    Any views expressed in this article are those of the author(s) and do not necessarily reflect the views of Life Risk News or its publisher, the European Life Settlement Association

    2023 - February Clinical Mortality Commentary Longevity Risk Volume 2 Issue 2 - February 2023
    Share. Twitter LinkedIn Email

    Related Posts

    Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    July 23, 2026By LMI Newsdesk

    Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

    July 23, 2026By LMI Newsdesk

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026By Mark McCord
    Litigation

    Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

    July 22, 2026By Greg Winterton
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.